Showing results (91-100 of 674) with videos related to

Sort By:
Pageof 68
Current Opinion in Pharmacology|November 18, 2017
Purinergic drug targets for gastrointestinal disordersGeoffrey Burnstock, Kenneth A Jacobson, Fievos L Christofi
JACS Au|January 31, 2025
Abraham Patchornik: The Contemporary Relevance of His Work for Chemistry and BiologyKenneth A Jacobson, Graham C R Ellis-Davies
Drug Development Research|January 1, 2025
Adenosine A1 and A3 Receptors: Distinct CardioprotectionBruce T Liang, Douglas Stewart, Kenneth A Jacobson
Drug Development Research|January 19, 2024
1,3-Dialkylxanthine Derivatives Having High Potency as Antagonists at Human A2B Adenosine ReceptorsKenneth A Jacobson, Ad P IJzerman, Joel Linden
Drug Development Research|January 22, 2024
Effects of Combinations of Methylxanthines and Adenosine Analogs on Locomotor Activity in Control and Chronic Caffeine-Treated MiceOlga Nikodijević, Kenneth A Jacobson, John W Daly
International Review of Neurobiology|September 23, 2023
A2A adenosine receptor agonists, antagonists, inverse agonists and partial agonistsKenneth A Jacobson, R Rama Suresh, Paola Oliva
Biochemical Pharmacology|November 10, 2009
UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulationZhan-Guo Gao, Yi Ding, Kenneth A Jacobson
Pageof 68